Post-Operative Pain Therapeutics Pipeline Analysis 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • ID: 4340274
  • Report
  • 158 pages
  • P&S Market Research
1 of 3
Disease Overview

Pain is an intricate sensation that differs in every individual, even if the cause or the injury is similar. The intensity of pain can be a dull aching or an instant sensation. It may feel like an inexplicable, irritating tickle on the skin. Pain, if left untreated for a long period, negatively impact a person’s mood and well-being. It occurs when the electrical signal travels to the spinal cord due to activation of receptors, which is then transmitted to the brain. The spinal cord acts as a transmission center, where the pain signal can be targeted by blocking, enhancing or modifying before it reaches to the brain. It involves the interaction of various chemicals, known as neurotransmitters, in the body, which together act to produce the sensation of pain. The intensity of pain can be acute or chronic depending upon the time it lasts. There are various types of pain such as nociceptive pain, inflammatory pain, pathologic pain, cancer pain, musculoskeletal pain and post-operative pain.

Post-operative pain is a very common problem after any surgery and it is necessary to treat the same effectively, so that the patient is more comfortable and positive, wounds heal better, there remains less risk for heart and lung complications, and patients are less likely to develop neuropathic pain.

Drug manufacturing companies are constantly involved in the quest to find better and new treatment strategies with potential targets such as sodium channel, opioid receptor and cyclooxygenase which can be effective in post-operative pain treatment. Various companies are developing drug candidates using advanced technologies, which is driving the growth of the pipeline.

Pipeline Analysis

As of July 2017, the post-operative pain therapeutics pipeline comprises of approximately 39 drug candidates in different stages of development.

Competitive Landscape

Some of the key players developing drugs for post-operative pain include DURECT Corporation, Elite Pharmaceuticals, Inc., Cara Therapeutics, Inc. and others.

Scope for Customization

Customization is offered as per specific business requirements of clients. Illustrative customization within the scope of this report includes:
  • Market Forecast - Market analysis and forecast for the drug candidates in the latest stage of development
  • Company Profiles - Wider company coverage in terms of detailed analysis or additional company profiles
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Research Background
1.1 Research Objectives
1.2 Definition
1.3 Research Scope
1.4 Key Stakeholders

2. Research Methodology
2.1 Secondary Research
2.2 Primary Research

3. Executive Summary

4. Pipeline Outlook
4.1 Overview
4.2 Key Drivers
4.3 Key Barriers
4.4 Post-Operative Pain Therapeutics Pipeline Analysis
4.4.1 Pipeline Analysis By Phase
4.4.2 Pipeline Analysis By Molecule Type
4.4.3 Pipeline Analysis By Route Of Administration
4.4.4 Pipeline Analysis By Company

5. Post-Operative Pain Therapeutics Pipeline Analysis By Phase (2017)
5.1 Pre-Registration: Drug Profiles
5.1.1 Pre-Clinical Study
5.1.2 Pre-Clinical Results
5.1.3 Clinical Trials
5.1.4 Clinical Results
5.1.5 Strategic Development
5.1.6 Designation
5.1.7 Grants
5.1.8 Patent
5.1.9 Technology
5.2 Phase Iii: Drug Profiles
5.2.1 Pre-Clinical Study
5.2.2 Pre-Clinical Results
5.2.3 Clinical Trials
5.2.4 Clinical Results
5.2.5 Strategic Development
5.2.6 Designation
5.2.7 Grants
5.2.8 Patent
5.2.9 Technology
5.3 Phase Ii: Drug Profiles
5.3.1 Pre-Clinical Study
5.3.2 Pre-Clinical Results
5.3.3 Clinical Trials
5.3.4 Clinical Results
5.3.5 Strategic Development
5.3.6 Designation
5.3.7 Grants
5.3.8 Patent
5.3.9 Technology
5.4 Phase I: Drug Profiles
5.4.1 Pre-Clinical Study
5.4.2 Pre-Clinical Results
5.4.3 Clinical Trials
5.4.4 Clinical Results
5.4.5 Strategic Development
5.4.6 Designation
5.4.7 Grants
5.4.8 Patent
5.4.9 Technology
5.5 Pre-Clinical: Drug Profiles
5.5.1 Pre-Clinical Study
5.5.2 Pre-Clinical Results
5.5.3 Strategic Development
5.5.4 Designation
5.5.5 Grants
5.5.6 Patent
5.5.7 Technology
5.6 Discovery: Drug Profiles
5.6.1 Strategic Development
5.6.2 Designation
5.6.3 Grants
5.6.4 Patent
5.6.5 Technology
5.7 Unknown: Drug Profiles
5.7.1 Pre-Clinical Study
5.7.2 Pre-Clinical Results
5.7.3 Clinical Trials
5.7.4 Clinical Results
5.7.5 Strategic Development
5.7.6 Designation
5.7.7 Grants
5.7.8 Patent
5.7.9 Technology

6 Competitive Landscape
6.1 Key Players Benchmarking For Post-Operative Pain Therapeutics Pipeline
6.2 Swot Analysis Of Post-Operative Pain Therapeutics Pipeline

7 Company Profiles
7.1 Business Overview
7.2 Product And Service Offerings

8 Appendix
8.1 Abbreviations

List Of Tables
Pipeline Analysis Of Post-Operative Pain Therapeutics, By Company (2017)
Description Of Pre-Registration Drug Candidates
Clinical Trials Of Pre-Registration Drug Candidates
Description Of Phase Iii Drug Candidates
Clinical Trials Of Phase Iii Drug Candidates
Description Of Phase Ii Drug Candidates
Clinical Trials Of Phase Ii Drug Candidates
Description Of Phase I Drug Candidates
Clinical Trials Of Phase I Drug Candidates
Description Of Pre-Clinical Drug Candidates
Description Of Discovery Drug Candidates
Description Of Unknown Phase Drug Candidates
Clinical Trials Of Unknown Phase Drug Candidates
Companies- At A Glance

List Of Figures
Research Methodology For Post-Operative Pain Therapeutics Pipeline Analysis
Split Of Primary And Secondary Research
Breakdown Of Primary Research Respondents, By Industry Participant
Breakdown Of Primary Research Respondents, By Company Type
Post-Operative Pain Therapeutics Drug Candidates Under Development (2017)
Post-Operative Pain Therapeutics Pipeline Split, By Molecule Type (2017)
Post-Operative Pain Therapeutics Pipeline Split, By Route Of Administration (2017)
Key Players Benchmarking For Post-Operative Pain Therapeutics Pipeline
Swot Analysis Of Post-Operative Pain Therapeutics Pipeline
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll